Pain News and Research

Latest Pain News and Research

AcelRx commences dosing in ARX-04 sufentanil NanoTab Phase 2 study for acute and breakthrough pain

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has dosed the first subjects in a Phase 2, placebo-controlled, dose-finding study of its ARX-04 sufentanil NanoTab product candidate.

5 Nov 2012

Study compares effectiveness of CABG surgery with PCI for adults with diabetes and heart disease

Adults with diabetes and multi-vessel coronary heart disease who underwent cardiac bypass surgery had better overall heart-related outcomes than those who underwent an artery-opening procedure to improve blood flow to the heart muscle, according to the results from an international study. The research was supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

5 Nov 2012

Study highlights potential treatment that reduces kidney growth

Autosomal-dominant polycystic kidney disease (ADPKD) is one of the most common genetic disorders, affecting one in every 1,000 people and responsible for up to ten percent of patients on dialysis worldwide. The disease is characterized by the development of cysts that lead to progressive kidney failure and necessitate dialysis or a kidney transplant in most patients aged around fifty. Moreover, the persistent cyst growth causes high blood pressure and painful complications.

5 Nov 2012

Pradaxa use does not appear to increase serious bleeding

The U.S. Food and Drug Administration (FDA) today announced the results of a Mini-Sentinel assessment that indicates bleeding rates associated with new use of Pradaxa (dabigatran etexilate mesylate) capsules do not appear to be higher than bleeding rates associated with new use of warfarin, which is consistent with observations from the pivotal RE-LY trial.

4 Nov 2012

Mass. adopts stricter rules, penalties for compounding pharmacies

The emergency regulations will allow the state to monitor contamination and the volume of medicines being made.

3 Nov 2012

First study to measure minute changes in breast tumor connective tissue fibers

Using advanced microscopes equipped with tissue-penetrating laser light, cancer imaging experts at Johns Hopkins have developed a promising, new way to accurately analyze the distinctive patterns of ultra-thin collagen fibers in breast tumor tissue samples and to help tell if the cancer has spread.

3 Nov 2012

BeamPath ROBOTIC system from OmniGuide used in Laparoscopic Myomectomy

Antonio R. Gargiulo, MD of the Center for Infertility and Reproductive Surgery at Brigham and Women's Hospital completed a live surgery for the American Society of Reproductive Medicine, treating a patient suffering from uterine fibroids with a novel robotic surgical approach and a cutting edge laser technology developed at OmniGuide in Cambridge, MA.

3 Nov 2012

People's reactions to stressors determine health consequences, say Penn State researchers

Contrary to popular perception, stressors don't cause health problems -- it's people's reactions to the stressors that determine whether they will suffer health consequences, according to researchers at Penn State.

3 Nov 2012

Viewpoints: Romney, Obama offer their 'visions for America;' One liberal wary of Mass. effort on assisted suicide

Change is an America where we reduce our deficit by cutting spending where we can, and asking the wealthiest Americans to go back to the income tax rates they paid when Bill Clinton was president. I've worked with Republicans to cut a trillion dollars of spending, and I'll do more. I'll work with anyone of any party to move this country forward. But I won't agree to eliminate health insurance for millions of poor, elderly, or disabled on Medicaid, or turn Medicare into a voucher just to pay for another millionaire's tax cut.

3 Nov 2012

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

Bristol-Myers Squibb Company is pleased to announce that today the National Institute of Health and Clinical Excellence (NICE) has decided to recommend YERVOY (ipilimumab), which is approved in the European Union for the treatment of previously-treated metastatic (advanced) melanoma, within the Final Appraisal Determination (FAD).

3 Nov 2012

Baylor University receives two new federal grants for research on Gulf War illness

Baylor University has been awarded two new federal grants for research on Gulf War illness, the complex medical condition that affects veterans of the 1991 war. The grants, from the Office of Congressionally Directed Medical Research Programs of the U.S. Department of Defense, total nearly $1.6 million, and bring current federal funding for Baylor's Gulf War research program to over $2.3 million.

3 Nov 2012

Hospital for Special Surgery physical therapist offers marathon recovery tips

Close to 47,000 runners have spent the past several months training for the ING New York City Marathon. Once they have completed the race and achieved their goals, there are measures they can take to facilitate recovery, decrease post-race discomfort, and return to running without injury.

3 Nov 2012

Treatments and outcomes vary for nursing home residents who use Medicare SNF care: Study

A Medicare rule that blocks thousands of nursing home residents from receiving simultaneous reimbursement for hospice and skilled nursing facility care at the end of life may result in those residents receiving more aggressive treatment and hospitalization, according a new analysis.

3 Nov 2012

Bypass surgery offers people with diabetes better long-term survival than stents

People with diabetes mellitus who undergo heart bypass surgery for multiple blocked arteries have a significantly better 5-year-survival rate than diabetic patients who undergo angioplasty with drug-eluting stents (DES), according to a study published in the November 2012 issue of The Annals of Thoracic Surgery.

3 Nov 2012

Pain News and Research

Latest Pain News and Research

AcelRx commences dosing in ARX-04 sufentanil NanoTab Phase 2 study for acute and breakthrough pain

Study compares effectiveness of CABG surgery with PCI for adults with diabetes and heart disease

Study highlights potential treatment that reduces kidney growth

Pradaxa use does not appear to increase serious bleeding

Mass. adopts stricter rules, penalties for compounding pharmacies

First study to measure minute changes in breast tumor connective tissue fibers

BeamPath ROBOTIC system from OmniGuide used in Laparoscopic Myomectomy

People's reactions to stressors determine health consequences, say Penn State researchers

Viewpoints: Romney, Obama offer their 'visions for America;' One liberal wary of Mass. effort on assisted suicide

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

Baylor University receives two new federal grants for research on Gulf War illness

Hospital for Special Surgery physical therapist offers marathon recovery tips

Treatments and outcomes vary for nursing home residents who use Medicare SNF care: Study

Bypass surgery offers people with diabetes better long-term survival than stents

Researcher identifies 71 genetic regions newly associated with inflammatory bowel disease

TD-1211 may relieve opioid-induced constipation

Imatinib mesylate effectively treats children with neurofibromatosis type 1 tumors

Cardio exercise OK in high-risk CVD patients

Partial dentin removal superior to stepwise excavation over long term

Genetic underpinning of placebo effect identified

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in